124 related articles for article (PubMed ID: 22846197)
1. Subclassification of non-small cell lung cancer by cytologic sampling: a logical approach with selective use of immunocytochemistry.
Kimbrell HZ; Gustafson KS; Huang M; Ehya H
Acta Cytol; 2012; 56(4):419-24. PubMed ID: 22846197
[TBL] [Abstract][Full Text] [Related]
2. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
3. Reliability of cytologic diagnosis of early lung cancer.
Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
[TBL] [Abstract][Full Text] [Related]
4. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
Noh S; Shim H
Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
[TBL] [Abstract][Full Text] [Related]
5. Non-small-cell lung carcinoma subtyping on cytology without the use of immunohistochemistry - can we meet the challenge?
Manucha V; Wang C; Huang Y
Acta Cytol; 2012; 56(4):413-8. PubMed ID: 22846184
[TBL] [Abstract][Full Text] [Related]
6. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
[TBL] [Abstract][Full Text] [Related]
7. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
8. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
9. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
10. Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas.
Sinna EA; Ezzat N; Sherif GM
J Egypt Natl Canc Inst; 2013 Dec; 25(4):209-18. PubMed ID: 24207093
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
Zachara-Szczakowski S; Verdun T; Churg A
Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of cell block as an adjunct to liquid-based cytology of bronchial washing specimens in the diagnosis and subclassification of pulmonary neoplasms.
Collins GR; Thomas J; Joshi N; Zhang S
Cancer Cytopathol; 2012 Apr; 120(2):134-41. PubMed ID: 21751430
[TBL] [Abstract][Full Text] [Related]
13. Bronchoscopic and transthoracic cytology and biopsy for pulmonary nonsmall cell carcinomas: performance characteristics by procedure and tumor type.
Tochigi N; Dacic S; Ohori NP
Diagn Cytopathol; 2012 Aug; 40(8):659-63. PubMed ID: 21319328
[TBL] [Abstract][Full Text] [Related]
14. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material.
Kalhor N; Zander DS; Liu J
Mod Pathol; 2006 Aug; 19(8):1117-23. PubMed ID: 16680154
[TBL] [Abstract][Full Text] [Related]
15. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.
Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC
Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598
[TBL] [Abstract][Full Text] [Related]
16. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.
Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M
Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
[TBL] [Abstract][Full Text] [Related]
18. Subtyping of nonsmall cell lung cancer on cytology specimens: reproducibility of cytopathologic diagnoses on sparse material.
Omland SH; Henrik H; Olsen EK; Birthe T; Guldhammer SB
Diagn Cytopathol; 2014 Feb; 42(2):105-10. PubMed ID: 23687077
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic reliability of cytologic typing in primary lung cancer with a review of the literature.
Suprun H; Pedio G; Ruttner JR
Acta Cytol; 1980; 24(6):494-500. PubMed ID: 6255714
[TBL] [Abstract][Full Text] [Related]
20. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
